SRTA

Strata Critical Medical, Inc. Class A Common Stock

4.90 USD
+0.37
8.17%
At close Updated Sep 16, 4:00 PM EDT
Pre-market
After hours
5.00
+0.10
2.04%
1 day
8.17%
5 days
18.64%
1 month
17.51%
3 months
22.81%
6 months
54.09%
Year to date
15.29%
1 year
55.06%
5 years
-51.49%
10 years
-49.74%
 

About: Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.

Employees: 322

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

59% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 29

53% more capital invested

Capital invested by funds: $117M [Q1] → $179M (+$62.4M) [Q2]

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

5% more funds holding

Funds holding: 117 [Q1] → 123 (+6) [Q2]

1.54% more ownership

Funds ownership: 53.32% [Q1] → 54.86% (+1.54%) [Q2]

66% less call options, than puts

Call options by funds: $1.51M | Put options by funds: $4.48M

Financial journalist opinion

Based on 3 articles about SRTA published over the past 30 days

Neutral
GlobeNewsWire
18 hours ago
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA (1) in the full-year 2025, with revenue expected to grow more than 50% in 2025 versus 2024 Acquisition follows multi-year partnership between Strata and Keystone whereby Keystone has successfully recovered hundreds of organs on behalf of Strata customers $124 million acquisition represents an approximate 9x multiple of 2025 estimated Adjusted EBITDA (1) ; Keystone's go forward Free Cash Flow (1) conversion is expected to be approximately 80% NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced that it has completed the acquisition of Keystone Perfusion Services LLC ("Keystone"), one of the largest organ recovery and normothermic regional perfusion ("NRP") service providers to the transplant industry and an industry leader in perfusion and other critical medical solutions for hospitals in non-transplant surgeries nationwide.
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
Neutral
GlobeNewsWire
18 days ago
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/news-events.
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference
Neutral
GlobeNewsWire
18 days ago
Blade Completes Sale of Passenger Business and Planned Name Change to Strata Critical Medical, Begins Trading Under Ticker Symbol SRTA
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced the successful closing of the previously announced divestiture of the Company's Passenger business to Joby Aviation, Inc. (NYSE: JOBY). Joby has elected to pay the up-front consideration in stock. The Company may receive up to an additional $35.0 million in consideration based on maintaining certain employee retention and financial performance targets during the 18 and 12 months, respectively, following today's closing, as well as the release of up to $10.0 million in indemnity holdbacks, payable in cash or stock at Joby's election.
Blade Completes Sale of Passenger Business and Planned Name Change to Strata Critical Medical, Begins Trading Under Ticker Symbol SRTA
Charts implemented using Lightweight Charts™